Market Analysis and Insights: Global Point-of-Care Infectious Disease Diagnostics/Testing Market
The global Point-of-Care Infectious Disease Diagnostics/Testing market size is projected to reach US$ 1452 million by 2026, from US$ 1056.5 million in 2020, at a CAGR of 5.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Point-of-Care Infectious Disease Diagnostics/Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Point-of-Care Infectious Disease Diagnostics/Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Point-of-Care Infectious Disease Diagnostics/Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Point-of-Care Infectious Disease Diagnostics/Testing market.
Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Type
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Based on regional and country-level analysis, the Point-of-Care Infectious Disease Diagnostics/Testing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Point-of-Care Infectious Disease Diagnostics/Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Abbott
Thermo Fisher Scientific Inc
F. Hoffmann-La Roche Ltd
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
The global Point-of-Care Infectious Disease Diagnostics/Testing market size is projected to reach US$ 1452 million by 2026, from US$ 1056.5 million in 2020, at a CAGR of 5.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Point-of-Care Infectious Disease Diagnostics/Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Point-of-Care Infectious Disease Diagnostics/Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Point-of-Care Infectious Disease Diagnostics/Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Point-of-Care Infectious Disease Diagnostics/Testing market.
Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Type
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Based on regional and country-level analysis, the Point-of-Care Infectious Disease Diagnostics/Testing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Point-of-Care Infectious Disease Diagnostics/Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Abbott
Thermo Fisher Scientific Inc
F. Hoffmann-La Roche Ltd
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 HIV POC
1.2.3 Clostridium difficile POC
1.2.4 HBV POC
1.2.5 Pneumonia or Streptococcus associated infections
1.2.6 Respiratory syncytial virus (RSV) POC
1.2.7 HPV POC
1.2.8 Influenza/Flu POC
1.2.9 Other Infectious Disease POC
1.3 Market by Application
1.3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Perspective (2015-2026)
2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Growth Trends by Regions
2.2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Share by Regions (2015-2020)
2.2.3 Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Market Size
3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Revenue (2015-2020)
3.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Players (2015-2020)
3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics/Testing Revenue
3.4 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio
3.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
3.5 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Area Served
3.6 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
3.7 Date of Enter into Point-of-Care Infectious Disease Diagnostics/Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Type (2015-2026)
4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Type (2015-2020)
4.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Type (2021-2026)
5 Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Application (2015-2026)
5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Application (2015-2020)
5.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
6.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
6.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
6.4 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
7.2 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
7.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
7.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
8.2 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
8.3 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
8.4 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
9.2 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
9.3 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
9.4 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
10.2 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020))
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Details
11.2.2 Thermo Fisher Scientific Inc Business Overview
11.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.2.5 Thermo Fisher Scientific Inc Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.4.5 Siemens Healthineers Recent Development
11.5 BD & Company
11.5.1 BD & Company Company Details
11.5.2 BD & Company Business Overview
11.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.5.5 BD & Company Recent Development
11.6 Chembio Diagnostics Inc.
11.6.1 Chembio Diagnostics Inc. Company Details
11.6.2 Chembio Diagnostics Inc. Business Overview
11.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.6.5 Chembio Diagnostics Inc. Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Details
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.7.5 Trinity Biotech Recent Development
11.8 Cardinal Health
11.8.1 Cardinal Health Company Details
11.8.2 Cardinal Health Business Overview
11.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.8.5 Cardinal Health Recent Development
11.9 Quest Diagnostics Inc.
11.9.1 Quest Diagnostics Inc. Company Details
11.9.2 Quest Diagnostics Inc. Business Overview
11.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.9.5 Quest Diagnostics Inc. Recent Development
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Details
11.10.2 Bio-Rad Labs Inc. Business Overview
11.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.10.5 Bio-Rad Labs Inc. Recent Development
11.11 bioMérieux SA
10.11.1 bioMérieux SA Company Details
10.11.2 bioMérieux SA Business Overview
10.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.11.4 bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.11.5 bioMérieux SA Recent Development
11.12 Sight Diagnostics Ltd.
10.12.1 Sight Diagnostics Ltd. Company Details
10.12.2 Sight Diagnostics Ltd. Business Overview
10.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.12.5 Sight Diagnostics Ltd. Recent Development
11.13 Gene POC
10.13.1 Gene POC Company Details
10.13.2 Gene POC Business Overview
10.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.13.5 Gene POC Recent Development
11.14 Trivitron Healthcare
10.14.1 Trivitron Healthcare Company Details
10.14.2 Trivitron Healthcare Business Overview
10.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.14.5 Trivitron Healthcare Recent Development
11.15 OJ-Bio Ltd.
10.15.1 OJ-Bio Ltd. Company Details
10.15.2 OJ-Bio Ltd. Business Overview
10.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.15.5 OJ-Bio Ltd. Recent Development
11.16 Ortho-Clinical Diagnostics
10.16.1 Ortho-Clinical Diagnostics Company Details
10.16.2 Ortho-Clinical Diagnostics Business Overview
10.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.16.5 Ortho-Clinical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 HIV POC
1.2.3 Clostridium difficile POC
1.2.4 HBV POC
1.2.5 Pneumonia or Streptococcus associated infections
1.2.6 Respiratory syncytial virus (RSV) POC
1.2.7 HPV POC
1.2.8 Influenza/Flu POC
1.2.9 Other Infectious Disease POC
1.3 Market by Application
1.3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Perspective (2015-2026)
2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Growth Trends by Regions
2.2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Share by Regions (2015-2020)
2.2.3 Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Market Size
3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Revenue (2015-2020)
3.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Players (2015-2020)
3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics/Testing Revenue
3.4 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio
3.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
3.5 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Area Served
3.6 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
3.7 Date of Enter into Point-of-Care Infectious Disease Diagnostics/Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Type (2015-2026)
4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Type (2015-2020)
4.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Type (2021-2026)
5 Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Application (2015-2026)
5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Application (2015-2020)
5.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
6.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
6.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
6.4 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
7.2 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
7.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
7.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
8.2 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
8.3 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
8.4 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
9.2 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
9.3 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
9.4 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
10.2 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020))
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Details
11.2.2 Thermo Fisher Scientific Inc Business Overview
11.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.2.5 Thermo Fisher Scientific Inc Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.4.5 Siemens Healthineers Recent Development
11.5 BD & Company
11.5.1 BD & Company Company Details
11.5.2 BD & Company Business Overview
11.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.5.5 BD & Company Recent Development
11.6 Chembio Diagnostics Inc.
11.6.1 Chembio Diagnostics Inc. Company Details
11.6.2 Chembio Diagnostics Inc. Business Overview
11.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.6.5 Chembio Diagnostics Inc. Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Details
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.7.5 Trinity Biotech Recent Development
11.8 Cardinal Health
11.8.1 Cardinal Health Company Details
11.8.2 Cardinal Health Business Overview
11.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.8.5 Cardinal Health Recent Development
11.9 Quest Diagnostics Inc.
11.9.1 Quest Diagnostics Inc. Company Details
11.9.2 Quest Diagnostics Inc. Business Overview
11.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.9.5 Quest Diagnostics Inc. Recent Development
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Details
11.10.2 Bio-Rad Labs Inc. Business Overview
11.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.10.5 Bio-Rad Labs Inc. Recent Development
11.11 bioMérieux SA
10.11.1 bioMérieux SA Company Details
10.11.2 bioMérieux SA Business Overview
10.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.11.4 bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.11.5 bioMérieux SA Recent Development
11.12 Sight Diagnostics Ltd.
10.12.1 Sight Diagnostics Ltd. Company Details
10.12.2 Sight Diagnostics Ltd. Business Overview
10.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.12.5 Sight Diagnostics Ltd. Recent Development
11.13 Gene POC
10.13.1 Gene POC Company Details
10.13.2 Gene POC Business Overview
10.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.13.5 Gene POC Recent Development
11.14 Trivitron Healthcare
10.14.1 Trivitron Healthcare Company Details
10.14.2 Trivitron Healthcare Business Overview
10.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.14.5 Trivitron Healthcare Recent Development
11.15 OJ-Bio Ltd.
10.15.1 OJ-Bio Ltd. Company Details
10.15.2 OJ-Bio Ltd. Business Overview
10.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.15.5 OJ-Bio Ltd. Recent Development
11.16 Ortho-Clinical Diagnostics
10.16.1 Ortho-Clinical Diagnostics Company Details
10.16.2 Ortho-Clinical Diagnostics Business Overview
10.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.16.5 Ortho-Clinical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
